tiprankstipranks
Bristol-Myers Squibb (BMY)
NYSE:BMY
Holding BMY?
Track your performance easily

Bristol-Myers Squibb (BMY) Ownership - Who Owns Bristol-Myers Squibb?

10,972 Followers

Bristol-Myers Squibb (BMY) Ownership Overview

0.07%21.58%15.32%24.04%38.99%
15.32% Other Institutional Investors
24.04% ETFs
38.99% Public Companies and Individual Investors
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail, and individual investors. Approximately 60.94% of the company’s stock is owned by Institutional Investors, 0.07% is owned by Insiders, and 38.99% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 05, 2024
Phil M Holzer
Svp & Controller
xxxxxxxxxxxxx
$38927
Nov 05, 2024
Samit Hirawat
Evp,chief Med.offr.,drug Dev
xxxxxxxxxxxxx
$100046
Dec 07, 2023
xxxxxxxxxxxxx
$99560
Nov 30, 2023
xxxxxxxxxxxxx
$150049

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
164,114,304Institution8.09%9,556,375,922
135,094,904Institution6.66%7,866,576,260
86,168,159Institution4.25%5,017,571,899
77,568,235Institution3.82%4,516,798,324
56,306,382Institution2.78%3,278,720,624
33,597,061Institution1.66%1,956,356,862
23,369,570Institution1.15%1,360,810,061
16,897,192Institution0.83%983,923,490
15,627,743Institution0.77%910,003,475
15,093,707Institution0.74%878,906,559

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
135,094,904Institution6.66%7,866,576,260
33,597,061Institution1.66%1,956,356,862
16,897,192Institution0.83%983,923,490
14,417,948Institution0.71%839,557,112
12,628,880Institution0.62%735,379,682
12,346,991Institution0.61%718,965,286
12,002,001Institution0.59%698,876,518
11,822,839Institution0.58%688,443,915
10,071,091Institution0.50%586,439,629
9,812,178Institution0.48%571,363,125

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
63,980,014Institution3.15%3,568,165,381
53,734,455Institution2.65%2,996,770,555
50,753,119Institution2.50%2,937,590,528
25,375,403Institution1.25%1,477,609,717
25,127,051Institution1.24%1,454,353,712
22,631,840Institution1.12%1,317,852,043
17,200,606Institution0.85%959,277,797
14,987,908Institution0.74%867,500,115
9,938,638Institution0.49%575,248,367
8,187,273Institution0.40%476,744,907

FAQ

Who Owns Bristol-Myers Squibb (BMY)?
According to the latest TipRanks data, approximately 15.32% of the company's stock is held by institutional investors, 0.07% is held by insiders, and 38.99% is held by retail investors.
    What percentage of Bristol-Myers Squibb (BMY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 15.32% of Bristol-Myers Squibb (BMY) stock is held by institutional investors.
      What percentage of Bristol-Myers Squibb (BMY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 38.99% of Bristol-Myers Squibb (BMY) stock is held by retail investors.
        Who owns the most shares of Bristol-Myers Squibb (BMY)?
        Vanguard owns the most shares of Bristol-Myers Squibb (BMY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis